Stoke Therapeutics: general counsel & corp sec Allan Jonathan sold 627 shares

What happened Allan Jonathan, general counsel & corp sec, sold 627 shares at $26.33 per share on Oct 2, 2026, for $16,509. The filing lists the sale as an open market or private sale (code S) and includes a footnote that the transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on Nov 10, 2025.

Key details

• Transaction date and price: Oct 2, 2026 — 627 shares at $26.33 per share; total proceeds $16,509.
• Sale type and code: Open market or private sale (code S).
• Shares owned after the transaction: not reported in the filing.
• Form 4 filed on Oct 2, 2026 (period of report Oct 2, 2026).
• Footnote: transaction executed pursuant to a Rule 10b5-1 trading plan adopted on Nov 10, 2025.

Why it may matter

• The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on Nov 10, 2025.
• The filing does not show why the insider traded or why the company acted.